Wanbury Limited (WANBURY) - Total Liabilities
Based on the latest financial reports, Wanbury Limited (WANBURY) has total liabilities worth Rs3.49 Billion INR (≈ $37.78 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Wanbury Limited net asset momentum to track the company's year-over-year net asset growth rate.
Wanbury Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Wanbury Limited's total liabilities have evolved over time, based on quarterly financial data. See WANBURY free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Wanbury Limited Competitors by Total Liabilities
The table below lists competitors of Wanbury Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OncoQuest Pharmaceuticals Inc
KQ:078590
|
Korea | ₩19.38 Billion |
|
Firefly AB (publ)
ST:FIRE
|
Sweden | Skr118.78 Million |
|
Grupo Sports World S.A.B. de C.V
MX:SPORTS
|
Mexico | MX$995.03 Million |
|
Pha Lai Thermal Power JSC
VN:PPC
|
Vietnam | ₫865.81 Billion |
|
Schloss Wachenheim AG
F:SWA
|
Germany | €260.86 Million |
|
NIBEC Co. Ltd
KQ:138610
|
Korea | ₩16.59 Billion |
|
Ferronordic AB (publ)
ST:FNM
|
Sweden | Skr3.17 Billion |
|
Comscore Inc
NASDAQ:SCOR
|
USA | $206.55 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Wanbury Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Wanbury Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Wanbury Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Wanbury Limited (2006–2025)
The table below shows the annual total liabilities of Wanbury Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs3.55 Billion ≈ $38.35 Million |
+12.39% |
| 2024-03-31 | Rs3.16 Billion ≈ $34.13 Million |
-6.18% |
| 2023-03-31 | Rs3.36 Billion ≈ $36.37 Million |
-10.54% |
| 2022-03-31 | Rs3.76 Billion ≈ $40.66 Million |
-15.59% |
| 2021-03-31 | Rs4.45 Billion ≈ $48.17 Million |
+5.51% |
| 2020-03-31 | Rs4.22 Billion ≈ $45.65 Million |
-14.77% |
| 2019-03-31 | Rs4.95 Billion ≈ $53.57 Million |
+8.29% |
| 2018-03-31 | Rs4.57 Billion ≈ $49.47 Million |
-19.07% |
| 2017-03-31 | Rs5.65 Billion ≈ $61.12 Million |
+3.59% |
| 2016-03-31 | Rs5.46 Billion ≈ $59.00 Million |
-4.77% |
| 2015-03-31 | Rs5.73 Billion ≈ $61.96 Million |
+0.32% |
| 2014-03-31 | Rs5.71 Billion ≈ $61.76 Million |
-28.09% |
| 2013-03-31 | Rs7.94 Billion ≈ $85.89 Million |
+7.34% |
| 2012-03-31 | Rs7.40 Billion ≈ $80.01 Million |
+12.72% |
| 2011-03-31 | Rs6.56 Billion ≈ $70.99 Million |
+6.91% |
| 2010-03-31 | Rs6.14 Billion ≈ $66.40 Million |
-9.07% |
| 2009-03-31 | Rs6.75 Billion ≈ $73.02 Million |
+252.95% |
| 2007-03-31 | Rs1.91 Billion ≈ $20.69 Million |
+104.02% |
| 2006-03-31 | Rs937.71 Million ≈ $10.14 Million |
-- |
About Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more